In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best global stocks to buy according to hedge funds. The United States has long been a magnet ...

FibroGen sells its China unit to AstraZeneca for about $160M, strengthening its cash position and extending its financial runway into 2027. AstraZeneca gains full rights to roxadustat in China ...

In its fourth quarter 2024 investor letter, Baron Health Care Fund emphasized stocks such as AstraZeneca PLC (NASDAQ:AZN). AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company that ...

34,658 people played the daily Crossword recently. Can you solve it faster than others?34,658 people played the daily Crossword recently. Can you solve it faster than others? A 55-year-old ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

AstraZeneca PLC (LON:AZN) announced a healthy earnings result recently, and the market rewarded it with a strong uplift in the stock price. This reaction by the market reaction is understandable ...

Shares of AZN opened at $73.58 on Friday. The company has a quick ratio of 0.71, a current ratio of 0.93 and a debt-to-equity ratio of 0.71. AstraZeneca has a 52-week low of $61.77 and a 52-week ...

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is ...

A class action lawsuit was filed against AstraZeneca Plc (AZN) by Levi & Korsinsky on December 23, 2024. The plaintiffs (shareholders) alleged that they bought AstraZeneca American Depositary ...